Abstract
The IFCC Committee on Clinical Applications of Cardiac Bio-Markers (C-CB) has directives and initiatives focused on providing evidence-based educational resources to aid and improve understanding around key analytical and clinical aspects of cardiac biomarkers used in clinical practice and the research setting. As a task force, we have previously published position statements and recommendations focused on use and analytical aspects of high-sensitivity cardiac troponin assays. The current educational document is the first from the C-CB highlighting important biochemical, analytical, and clinical aspects as they relate to the natriuretic peptides (NPs), including B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP), with a focus on heart failure.
Original language | English |
---|---|
Pages (from-to) | 1221-1227 |
Number of pages | 7 |
Journal | Clinical Chemistry |
Volume | 65 |
Issue number | 10 |
Early online date | 1 Oct 2019 |
DOIs | |
Publication status | Published - 4 Jan 2020 |